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INTRODUCTION
Adverse drug reactions are common, occurring in 7% of the 
general population and 10-20% of hospitalized patients.
1,2 Ap-
proximately 80% of adverse drug reactions are caused by the 
pharmacological properties of the causative drug (type A reac-
tions) and thus are predictable. However, 10-15% are unpredict-
able and occur in vulnerable subjects (type B reactions). Addi-
tionally, there are type C reactions, which are associated with 
long-term therapy and type D reactions, which produce terato-
genic and carcinogenic effects.
3 Approximately 5-10% of type B 
adverse drug reactions (hypersensitivity reactions) are non-al-
lergic and are induced by non-immunological mechanisms; 
other type B reactions are drug allergies that develop through 
immunological mechanisms induced by not only IgE- but also 
T cell-, or rarely immune complex-mediated reactions.
Skin tests for IgE-mediated immediate allergic reactions (type 
I hypersensitivity reactions) are frequently used to predict drug 
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allergy or hypersensitivity. Intradermal tests with readings taken 
at 24 to 48 hours and patch tests can be used for delayed reactions 
occurring more than 1 hour after drug administration; these re-
actions are mediated mainly by T cells.
2-4 A positive skin test for 
type I hypersensitivity is not always accompanied by drug aller-
gy symptoms, as occur with other allergic diseases. Although 
cephalosporins at concentrations of 2-3 mg/mL are usually non-
irritative, some cephalosporins produced false-positive reac-
tions in skin prick tests because of irritative effects.
2 Conversely, 
despite a negative penicillin skin prick test, penicillin allergy 
was evoked in 5.4% of patients with a positive history of penicil-
lin allergy, suggesting a substantial number of false-negative re-
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Purpose: Skin allergies through type 1 and 4 hypersensitivity reactions are the most frequent manifestations of drug allergies. We had previously 
experienced a case of a nurse with cefotiam-induced contact urticaria syndrome. To aid in preventing the progression of drug-induced allergic dis-
ease in nurses, we conducted a survey of tertiary hospital nurses who were likely to have been exposed professionally to antibiotics.  Methods:   
All 539 staff nurses at a tertiary hospital were asked to respond to a questionnaire regarding antibiotic exposure. Of the 457 nurses (84.8%) who re-
sponded, 427 (79.2%) received a physical examination of the hands and 318 (59.0%) received skin prick tests with the b-lactam antibiotics cefo-
tiam, cefoperazone, ceftizoxime, flomoxef, piperacillin and penicillin G.  Results:  A positive response to at least one of the antibiotics occurred in 8 
(2.6%) of the 311 subjects included in the analysis and stages 1 and 2 contact urticaria syndrome were observed in 38 (8.9%) and 3 (0.7%) of 427 
nurses, respectively. The frequencies of a positive antibiotic skin test (6.9 versus 1.3%, c2=7.15, P=0.018), stage 1 contact urticaria syndrome (14.4 
versus 7.4%, c2=4.33, P=0.038) and drug allergy (15.3 versus 3.6%, c2=18.28, P=0.000) were higher in subjects with a positive skin allergy history 
than in those without. Allergic rhinitis (P=0.02, OR=3.86, CI=1.23-12.06), night cough (P=0.04, OR=3.12, CI=1.03-9.41) and food allergy (P=0.00, 
OR=9.90, CI=3.38-29.98) were significant risk factors for drug allergy.  Conclusions:  Antibiotic sensitization and drug allergy occurred more fre-
quently in nurses with a positive skin allergy history. Atopy may be an important risk factor for drug allergy.
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actions.
2 Furthermore, although some antibiotics such as ce-
phalosporin, ciprofloxacin, trimethoprim and penicillin are 
able to elicit a positive type I hypersensitivity skin reaction, most 
low-molecular-weight drugs act as haptens only after their con-
version to reactive metabolites in the body; thus, skin testing 
with an unaltered drug may not identify a drug allergy.
5 Despite 
these limitations of skin tests, we believe, based on our recent 
case of cefotiam-contact anaphylaxis,
6 that skin tests for type I 
hypersensitivity to antibiotics should be performed in popula-
tions with the potential to develop drug allergies.
A search of the literature revealed that since the development 
of the second-generation cephalosporin cefotiam in 1981, there 
have been several cases of nurses with contact urticaria syn-
drome (CUS) due to cefotiam in Japan
7,8 and Korea.
9-14 More-
over, the disease was progressive, beginning as dermatitis local-
ized at the contact area, progressing to generalized urticaria in-
volving other organs and finally producing anaphylaxis. Our 
case showed not only a strong positive reaction to cefotiam on 
a skin test but also symptoms of CUS and a positive skin reac-
tion to cefoperazone/sulbactam.
6
As nurses are frequently exposed to antibiotics, drug sensiti-
zation and related allergy development should be monitored in 
this population. The early detection of drug allergies may pre-
vent their progression. In this study, we asked all staff nurses at 
a tertiary hospital to respond to a questionnaire regarding anti-
biotic exposure and respondents received a physical examina-
tion of the hands and type I hypersensitivity skin tests with sev-
eral common antibiotics.
MATERIALS AND METHODS
Subjects
For this study, a questionnaire regarding antibiotic exposure 
and signs of drug allergy was sent to all 539 nurses working at 
our university hospital in 2008. Of the 457 nurses (84.8%) who 
responded, 427 (79.2%) received a physical examination of the 
hands and 318 (59.0%) received skin tests. Subjects who did not 
provide consent were excluded from the study. Skin tests were 
not conducted in subjects who were or were thought to be preg-
nant or in those who had taken antihistamines within 1 week of 
the tests and could not discontinue antihistamine use for lon-
ger than 1 week. The study protocol was approved by our insti-
tutional review board (IRB No. I-2008-04-040).
Methods
After receiving the responses to the questionnaire and collect-
ing demographic and occupational information, including the 
duration of antibiotic exposure, consenting respondents re-
ceived a physical examination of the hands to detect any skin 
lesions and skin prick tests with common antibiotics. Available 
atopic allergy data were collected from hospital medical re-
cords. All data were collected by trained residents in the De-
partments of Internal Medicine and Dermatology or by trained 
nurses.
The questionnaire was constructed with reference to previous 
reports.
15,16 It contained items regarding the history of exposure 
to antibiotics, including the duration of employment and expe-
riences with injectable antibiotics and items for assessing the 
presence of allergic diatheses or diseases. Questions included 
the following: (1) Do you have common cold symptoms such as 
rhinorrhea and sneezing frequently or persistently? (2) Have 
you ever had dyspnea or wheezing? (3) Have you ever been awak-
ened due to a severe night cough? (4) Have you ever had urticar-
ia or dyspnea after eating? (5) Do you suffer from urticaria fre-
quently? (6) Have you ever experienced a drug allergy? (7) How 
long have you had the aforementioned allergic symptoms? (8) Is 
there any family history of the aforementioned allergic symp-
toms or diseases? Maculopapular or morbilliform rashes, which 
are the most frequent manifestations of drug allergy,
3 and con-
tact dermatitis due to metal, as in a necklace, are usually regard-
ed as type IV hypersensitivity reactions; however, these types of 
reactions were not queried separately in this study. Many sub-
jects with these reactions reported urticaria as an alternative 
and some subjects recorded metal contact allergy or atopic der-
matitis on the questionnaire form. Therefore, we classified urti-
caria, rash, contact dermatitis and atopic dermatitis as skin al-
lergies. Subjects responding positively to any of the first six ques-
tions above were considered to have an allergic condition.
We employed the CUS staging system proposed by Von Krogh 
and Maibach
17: stage 1, local urticaria on the contact area; stage 
2, generalized urticaria; stage 3, extracutaneous involvement 
(rhinoconjunctivitis, asthma, orolaryngeal or gastrointestinal); 
and stage 4, anaphylactic shock. For stage 1, a clinical diagnosis 
of contact urticaria was made by asking, “Does itching or urti-
caria develop a few minutes after contact with antibiotics?” A 
clinical diagnosis of allergic contact dermatitis was made when 
a physical examination found eczema on one or both hands. 
Eczema is difficult to associate with antibiotics, because it usu-
ally develops 12-48 hours after antibiotic contact.
18 For this rea-
son, eczema, which was probably related to rubber gloves, was 
also regarded as antibiotic-related eczema. For stage 2, skin 
rashes were observed at sites distant from the contact site. For 
stage 3, a history of allergic rhinitis, conjunctivitis, bronchial 
asthma or oropharyngeal/gastrointestinal symptoms after hand 
contact with antibiotics was determined. For stage 4, a history 
of dizziness, loss of consciousness or decrease in blood pres-
sure after hand contact with antibiotics was assessed. In addi-
tion, the symptom duration was recorded according to stage.
The Pharmaceutical Department of our hospital provided ceft-
izoxime, flomoxef, piperacillin, which are frequently prescribed 
antibiotics in our hospital, as well as cefotiam, cefoperazone and 
penicillin G, a representative antibiotic that often induces drug 
allergy. For the skin prick tests, penicillin G was used at 10,000 
U/mL and cefoperazone, ceftizoxime, flomoxef and piperacillin Allergy Asthma Immunol Res. 2010 April;2(2):114-122.  doi: 10.4168/aair.2010.2.2.114
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were each used at a concentration of 33 mg/mL. Cefotiam was 
used at a lower concentration (10 mg/mL) to avoid severe ad-
verse reactions, given that a nurse with cefotiam-contact ana-
phylaxis had previously shown a strong positive skin reaction 
and generalized allergic symptoms following a skin prick test us-
ing as little as 1 mg/mL cefotiam.
6 In addition to the six drugs, 
two house dust mites, Dermatophagoides farinae and D. pteron-
yssinus, which are the most common atopic allergens; 0.9% nor-
mal saline; and 1 mg/mL histamine were used as controls for the 
skin prick tests. For the skin prick test, the forearm skin was pricked 
with a sterile needle through a drop of the antibiotic and 15 min-
utes later, the longest wheal diameter and the diameter perpen-
dicular to it were measured using vernier calipers and then aver-
aged. Test results in subjects with dermographism were not used 
in the analysis. A positive reaction was defined as a mean wheal 
size was ≥3 mm and larger than the size of the negative control, 
according to the European Society of Contact Dermatitis guide-
lines.
19 For house dust mites, the ratio of the allergen wheal size 
relative to that of the histamine control (A/H ratio) was graded 
on a 4-point scale: 1+, 25-49%; 2+, 50-99%; 3+, 100-199%; and 4+, 
≥200%. The house dust mite results were considered as clinically 
significant positive when the A/H ratio was ≥3+.
20 When a medi-
cal chart was available, we collected data regarding the number 
of peripheral white blood cells, fraction of eosinophils, number 
of eosinophils (number of white blood cells×fraction of eosino-
phils) and serum total IgE measured by nephelometry (Behring 
Diagnostics, Marburg, Germany).
Statistical analysis
All statistical analyses were performed using SPSS 17.0 (SPSS 
Inc., Chicago, IL, USA). Data are expressed as the mean±SD. The 
prevalence of atopic allergy and the frequency of antibiotic sen-
sitization were analyzed using descriptive statistics. Differences 
in the results according to the test response to antibiotics or the 
history of skin allergies were examined using Student’s t-test, 
the c
2 test or Fisher’s exact test. Risk factors for a positive skin 
test to an antibiotic, CUS and drug allergy were analyzed with a 
logistic regression model. A P value <0.05 was considered statis-
tically significant.
RESULTS
Clinical characteristics of skin-tested and non-tested subjects
Table 1 shows the differences in clinical characteristics be-
tween subjects who received skin prick tests (number=318) and 
those who did not (number=139). There was no significant dif-
ference in age or employment duration between the groups. 
However, there were significantly more antibiotic handlers in 
the group that took skin tests than in the group that did not (P< 
0.001). The duration of contact with intravenous antibiotics did 
not differ significantly between the antibiotic handlers in each 
group. Approximately 50% of the subjects in each group had al-
lergic disease related to type I hypersensitivity and the preva-
lence of each disease was not significantly different between 
the groups. There was a trend toward a higher prevalence of 
drug allergy, especially antibiotic allergy, in the group that took 
the skin tests, but the difference was not statistically significant.
Stage 1 CUS was observed in 38 (8.9%) of the 427 subjects who 
underwent a physical examination, with localized urticaria ob-
served in 11 subjects (2.6%) and eczema observed in 38 (8.9%). 
Sixteen (44.4%) of the 38 stage 1 subjects exhibited stage 1 CUS 
on both hands. Stage 2 CUS was present in three subjects (0.7%) 
and stages 3 and 4 were not observed. Stages 1 and 2 urticaria 
developed only in the group who took the skin tests, but the dif-
ference was not statistically significant (Table 1). The groups 
with and without skin tests did not differ with respect to the num-
ber of subjects with eosinophils ≥450/mm
3 or with IgE ≥100 IU/
mL (with: 1/17, 5.9%; without: 1/6, 16.7%).
Prevalence of sensitization to antibiotics and CUS
Among the 318 subjects who took skin tests, 4 subjects who 
were negative for histamine sensitivity and 3 dermographic sub-
jects who were positive for normal saline were excluded from the 
skin test analysis. Eight (2.6%) of the remaining 311 subjects showed 
a positive response to at least one of the six test antibiotics.
Table 1.  Clinical characteristics of nurses with and without to antibiotic prick tests
Skin prick tests
(yes) (no)
No. of subjects 318 139
Male 1 1
Age (yr) 29.5±6.9 30.0±6.6
Length of employment (mo) 79.3±84.2 91.8±78.8
History of dermal contact with IV antibiotics (%) 303 (96.5) 98 (71.5)*
Duration of dermal contact with IV antibiotics (mo) 73.8±78.4 73.8±63.4
Duration of allergic diseases (mo) 48.6±74.2 72.9±97.3
Any allergy (%) 176 (55.3) 68 (48.9)
Allergic rhinitis (%) 113 (35.5) 47 (34.8)
Asthma (%) 5 (1.6) 3 (2.2)
Night cough (%) 36 (11.3) 11 (7.9)
Food allergy (%) 25 (7.9) 11 (7.9)
Skin allergy (%) 73 (23.0) 25 (18.0)
Drug allergy (%) 22 (6.9) 6 (4.3)
Antibiotic allergy (%) 9 (3.0) 0 (0)
Family history of allergy (%) 57 (18.0) 24 (17.4)
Contact urticaria syndrome
Stage 1 (%) 25 (7.9) 13 (11.9)
Urticaria (%) 11 (3.5) 0 (0)
Dermatitis (%) 25 (7.9) 13 (11.9)
Stage 2 (%) 3 (0.9) 0 (0)
Blood eosinophils >450/mm
3 (%) 9 (3.0) 1 (2.4)
*P<0.001.Allergy Asthma Immunol Res. 2010 April;2(2):114-122.  doi: 10.4168/aair.2010.2.2.114
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Among these eight, 3 were positive for cefotiam; 2, for cefoper-
azone; 4, for ceftizoxime; 5, for flomoxef; 4, for piperacillin; 5, for 
penicillin G; and 2, for all antibiotics (Table 2). Antibiotic-in-
duced CUS was observed in three subjects, all whom showed 
both localized urticaria and eczema. Two of these subjects were 
sensitized to cefotiam and showed stage 2 CUS; one was sensi-
tized to flomoxef and showed only stage 1 CUS. One subject who 
reported no use of antibiotics had a history of penicillin- and ce-
phalosporin-induced urticaria and abdominal pain; she showed 
positive reactions to penicillin G and flomoxef. One subject who 
had a positive reaction to antibiotics did not have any allergic 
symptoms. Only two of the eight subjects with positive reactions 
to antibiotics had a positive history of drug allergy and the oc-
currence of CUS was not related to drug allergy history.
Clinical characteristics according to skin test results
The eight subjects with positive responses to a skin prick test 
did not differ from those without a positive response (number= 
303) with respect to age, employment duration, positive history 
or duration of exposure to antibiotics (Table 3). However, a skin 
allergy history was significantly more prevalent in the group 
with a positive test than in the group without a positive test (62.5 
versus 22.1%; c
2=7.15; P=0.018). Allergic diseases (87.5 versus 
54.1%; c
2=3.51; P=0.078), drug allergies (25.0 versus 6.3%; c
2= 
4.34, P=0.095) and antibiotic allergies (14.3 versus 2.7%; c
2=3.12; 
P=0.194) tended to be more prevalent in the positive test group 
compared with the other group, although the differences were 
not statistically significant. Stage 1 CUS (37.5 versus 7.3%; 
c
2=9.64; P=0.020), localized urticaria (37.5 versus 2.6%; c
2=27.76; 
P=0.002]), eczema (37.5 versus 7.3%; c
2=9.64; P=0.020) and stage 
2 CUS (25.0 versus 0.3%; c
2=49.65; P=0.002) occurred more fre-
quently in the group with a positive test than in the group without 
a positive test. The time interval between stages 1 to 2 CUS was 
not obtained in the positive test group, but the interval was 14.3± 
14.0 months in the other group. There was no significant differ-
ence in the frequency of increased eosinophils in peripheral blood 
or sensitization to house dust mites between the two groups.
Clinical characteristics according to skin allergy history
Given the significant difference in the prevalence of skin aller-
gy history between the groups with and without a positive skin 
test, the clinical characteristics of the subjects were compared 
Table 2.  Clinical characteristics of nurses who showed a positive response to skin prick tests using antibiotics
Sex Age
Antibiotics
use
Any
allergy
AR
Skin
allergy
Drug
allergy
Contact urticaria syndrome Skin prick test
Stage 1 Urticaria Dermatitis Stage 2 ① ② ③ ④ ⑤ ⑥ ⑦
HHJ F 22 + + - + - - - - - + + + + + + -
AJP F 46 - + - - + - - - - - - - + - + -
HNP F 24 + + + + + - - - - - - - - - + -
HSS F 27 + + - + - + + + - - - - + - - -
JWP F 28 + - - - - - - - - - - + + + - -
MHY F 30 + + - - - + + + + + - + - + - -
KMH F 29 + + - + - + + + + + + + + + + -
MJY F 25 + + + + - - - - - - - - - - + -
① cefotiam, ② cefoperazone, ③ ceftizoxime, ④ flomoxef, ⑤ piperacillin, ⑥ penicillin G, ⑦ house dust mites.
Table 3.  Comparisons of clinical characteristics between positive and nega-
tive responders to antibiotic skin prick tests
Antibiotic prick tests
(+) (-)
No. of subjects 8 303
Male 0 1
Age (yr) 28.9±7.4 29.5±6.8
Length of employment (mo) 67.5±49.3 79.1±84.9
History of dermal contact with IV antibiotics (%) 7 (87.5) 289 (96.7)
Duration of dermal contact with IV antibiotics (mo) 53.9±33.1 74.0±79.0
Duration of allergic diseases (mo) 75.2±85.1 46.8±75.0
Any allergy (%) 7 (87.5) 164 (54.1)
Allergic rhinitis (%) 2 (25.0) 107 (35.3)
Asthma (%) 0 (0) 5 (1.7)
Night cough (%) 2 (25.0) 33 (10.9)
Food allergy (%) 1 (12.5) 23 (7.6)
Skin allergy (%) 5 (62.5) 67 (22.1)*
Drug allergy (%) 2 (25.0) 19 (6.3)
Antibiotic allergy (%) 1 (14.3) 8 (2.7)
Family history of allergy (%) 2 (28.6) 55 (18.2)
Contact urticaria syndrome
Stage 1 (%) 3 (37.5) 22 (7.3)*
Urticaria (%) 3 (37.5) 8 (2.6)
†
Dermatitis (%) 3 (37.5) 22 (7.3)*
Stage 2 (%) 2 (25.0) 1 (0.3)
†
Blood eosinophils >450/mm
3 (%) 0 (0) 9 (3.1)
(+) House dust mites (%) 0 (0) 59 (19.5)
Dermatophagoides pteronyssinus grade 0.50±0.93 0.63±1.23
Dermatophagoides farinae grade 0.50±0.93 0.53±1.12
*P< 0.05, 
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according to skin allergy history. There were no significant dif-
ferences in age or employment duration between the subjects 
with a positive history of skin allergy (number=98) and those 
without (number=359); however, the duration of contact with 
antibiotics and duration of allergic diseases were significantly 
longer in the group with a positive skin allergy history (Fig. 1). 
The number of eosinophils in peripheral blood tended to be 
higher in the group with a positive skin allergy history than in 
the group without a positive history, but the proportion of sub-
jects with an eosinophil count ≥450/mm
3 was not significantly 
different between the groups (5.1 versus 2.2%; c
2=1.78; P=0.242). 
The frequencies of a positive drug allergy history (15.3 versus 
3.6%; c
2=18.28; P=0.000), stage 1 CUS (14.4 versus 7.4%; c
2=4.33; 
P=0.038) and positive antibiotic skin test responders (6.9 versus 
1.3%; c
2=7.15; P=0.018) were higher in the group with than 
without a positive skin allergy history. Stage 2 CUS (2.2 versus 
0.3%; c
2=3.77; P=0.114]) and stage 1 localized urticaria (4.4 ver-
sus 2.1%; c
2=1.59; P=0.255) tended to be more prevalent in the 
group with a positive history (Fig. 2), but the differences be-
tween the groups with and without a positive history were not 
statistically significant.
Clinical characteristics according to drug allergy history
The subjects with a drug allergy history (number=28) were sig-
nificantly older and had a longer employment duration, longer 
duration of contact with antibiotics and higher prevalences of 
allergic rhinitis, night cough, food allergy and skin allergy com-
pared with the subjects without a drug allergy history (number= 
429) (Table 4). Moreover, the grade of the skin test reactivity to 
D. farinae was significantly higher in the subjects with a drug al-
lergy than in the other group.
Risk factors for positive drug skin tests, CUS and drug allergies
According to the univariate analysis, the significant risk fac-
tors for a positive response to the drug skin tests were a positive 
history of skin allergy, stage 1 CUS (localized urticaria) and stage 
2 CUS (generalized urticaria). The risk factors in the multivari-
ate analysis were a positive history of drug allergy and localized 
stage 1 CUS (Table 5). According to the univariate analysis, the 
risk factors for stage 1 CUS were a positive history of any allergic 
disease, night cough, skin allergy and a positive response to the 
drug skin tests. Multivariate analysis showed the risk factors to 
be a positive history of any allergic disease and a positive re-
sponse to the drug skin tests. For localized contact urticaria, the 
risk factors were a positive history of any allergic disease and 
positive response to the drug skin tests based on univariate anal-
ysis and a positive history of asthma and positive response to 
the drug skin tests based on multivariate analysis. According to 
the univariate analysis, allergic rhinitis, night cough, food aller-
gy and skin allergy were risk factors for drug allergy. Age, aller-
gic rhinitis, night cough and food allergy were the risk factors 
for drug allergy according to the multivariate analysis.
DISCUSSION
The positive response rate to the 6 antibiotics was 6.9% in 
nurses with a positive history of skin allergy, 1.3% in those with-
out and 2.6% in all subjects. The prevalence of self-reported al-
Fig. 1.  The duration of dermal contact with antibiotics, duration of any allergic 
diseases and eosinophil counts in peripheral blood in nurses with and without a 
positive history of skin allergy in a tertiary hospital.
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lergy to penicillin or other b-lactam antibiotics according to 
Gomes et al.
21 was 6.0% in the general adult female population 
and the positive response rate to antibiotics in patients with a 
history of previous penicillin allergy was reported to be 14% by 
Solley et al.
22 and 8.7% by Raja et al.
23 Compared with these re-
ported rates,
21-23 the positive response rates in our study with 
nurses were relatively high.
The skin test response rate for a drug may be lower than the 
prevalence of an allergy history for that drug, because the posi-
tive response to a skin test will decrease as the antibody level 
decreases over time. Only 22% of patients with a penicillin al-
lergy showed a positive skin test response to penicillin 10 years 
after exposure.
24 The continual antibiotic exposure of the nurs-
es in the present study may explain their higher positive re-
sponse rate to antibiotic skin tests, compared with the rate of 
approximately 1% in the general adult population. Our results 
are supported by those of You et al.,
25 who found that positive 
response rates to patch tests were 10% for cefotaxime, 10% for 
neomycin and as high as 50% for vancomycin in 40 intensive 
care unit nurses who were suspected of high exposure to anti-
biotics. Even excluding vancomycin, because it is well known to 
non-immunologically release histamine and thus induce “red-
man syndrome,”
26 the positive response rates reported by You 
et al.
25 were relatively high. Of course, the study methods used 
by You et al.
25 differed from those in the present and previous 
studies.
22,23 You et al.
25 performed patch tests for T cell-mediat-
ed delayed adverse reactions and evaluated maculopapular 
and morbilliform skin rashes, a delayed reaction and common 
manifestation of drug allergy.
3 In contrast, we and earlier inves-
tigators
22,23 conducted prick or scratch skin tests for IgE-mediat-
ed immediate reactions such as urticaria. Barbaud et al.
27 
showed that in patients with cutaneous adverse reactions, the 
positive response rates to the drugs tested were 43% by the 
patch test and 24% by the skin prick test, suggesting a lower 
sensitivity for the skin prick test compared with the patch test. 
Furthermore, the prevalence of adverse reactions may differ 
between past and present cephalosporins; for example, the re-
action rate to cephalosporin decreased from 10-20% to 2% 
when the second-generation drug was used instead of the first-
generation drug, which showed cross-reactivity to penicillin.
28 
Considering these points, the sensitization rate to drugs may be 
higher in nurses than in the general population, owing to a 
more intense exposure of nurses to drugs.
In the present study, evidence for stage 1 CUS in response to 
an antibiotic was observed in 14.4% of the subjects with a posi-
tive skin allergy history, in 7.4% of those without and in 8.9% of 
all subjects; evidence for contact urticaria, in 4.4%, 2.1% and 
2.6%, respectively; and evidence for stage 2 CUS, in 2.2%, 0.3% 
and 0.7%, respectively. It was difficult to discriminate between 
antibiotic-induced CUS and contact dermatitis caused by other 
factors. Allergic contact dermatitis develops 12-48 hours after 
dermal contact with allergens.
18 In contrast, contact urticaria in-
duced by antibiotics usually manifests within a few minutes and 
thus was apparent. All subjects with eczema on their hands 
were considered to have stage 1 CUS and given that some of 
these cases were probably contact dermatitis due to the other 
causes, the prevalence of stage 1 CUS would have been inflated. 
However, considering the cases of antibiotic-induced contact 
dermatitis beside contact urticaria, the prevalence of stage 1 
would be higher than that of contact urticaria. Subjects with a 
positive skin test response to antibiotics showed a higher preva-
lence of stages 1 and 2 CUS, with 5.6 times the risk for stage 1 
and 24.9 times the risk for contact urticaria compared with sub-
jects without a positive skin test. This suggests that sensitization 
to antibiotics is strongly related to CUS.
Kim et al.
29 reported a case with cold urticaria that progressed 
to exercise-induced anaphylaxis. CUS is a good example of sim-
ilar events.
17 This study was conducted as a fact-finding survey 
to prevent the progression of antibiotic-induced CUS. We iden-
tified two subjects with stage 2 CUS who had a positive skin test 
reaction to cefotiam, a second-generation cephalosporin. In 
Korea, since the first case report of cefotiam-induced CUS by 
Table 4.  Comparisons of clinical characteristics according to the absence or 
presence of a positive history of drug allergy
Drug allergy history
(+) (-)
No. of subjects 28 429
Male 0 2
Age (yr) 32.5±7.8 29.5±6.7*
Length of employment (mo) 114.1±88.6 81.0±82.0*
History of dermal contact with IV antibiotics (%) 27 (96.4) 374 (88.4)
Duration of dermal contact with IV antibiotics (mo) 111.2±92.1 71.1±73.2*
Duration of allergic diseases (mo) 49.5±82.9 55.3±80.8
Any allergy (%) 28 (100) 216 (50.3)
†
Allergic rhinitis (%) 20 (71.4) 140 (32.9)
†
Asthma (%) 2 (7.1) 6 (1.4)
Night cough (%) 9 (32.1) 38 (8.9)
†
Food allergy (%) 12 (42.9) 24 (5.6)
†
Skin allergy (%) 15 (53.6) 83 (19.3)
†
Family history of allergy (%) 5 (19.2) 76 (17.7)
Contact urticaria syndrome
Stage 1 (%) 0 (0) 38 (9.4)
Urticaria (%) 0 (0) 11 (2.7)
Dermatitis (%) 0 (0) 38 (9.4)
Stage 2 (%) 0 (0) 3 (0.7)
Blood eosinophils >450/mm
3 (%) 2 (8.7) 8 (2.5)
(+) House dust mites (%) 6 (27.3) 54 (18.2)
Dermatophagoides pteronyssinus grade 0.86±1.32 0.62±1.21
Dermatophagoides farinae grade 1.23±1.45 0.48±1.07*
(+) Antibiotic skin tests (%) 2 (9.5) 6 (2.1)
*P< 0.05, 
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9 in 1998, 10 cases of cefotiam-induced CUS have been 
reported.
6,9-14,30 Cefotiam-induced CUS occurs mainly in nurses. 
Cefotiam is stored under vacuum; when the vacuum is released 
by a nurse, cefotiam becomes dispersed and is easily absorbed 
through damaged skin on the hands, where its irritative proper-
ties cause eczema.
12 Owing to this peculiar property, cefotiam 
appears to not only induce progression to CUS but also facili-
tate secondary CUS induced by cefoprazone/sulbactam
6 or im-
ipenem.
30 This phenomenon was observed in the present study: 
of the two cases of CUS sensitized to cefotiam, one was also sen-
sitized to ceftizoxime and piperacillin and the other showed pos-
itive reactions to all antibiotics tested. However, the one case of 
CUS sensitized to flomoxef was not sensitized to the other anti-
biotics and did not progress to stage 2.
Compared with those without a positive skin allergy history, 
the subjects with a positive skin allergy history had longer dura-
tions of contact with antibiotics and of allergic diseases and 
higher prevalences of drug allergy, CUS and positive skin reac-
tions to antibiotics. This may be attributable to the fact that skin 
allergy frequently develops in association with exposure and 
sensitization to antibiotics, which corresponds well with the re-
sults of a previous study by Gomes et al.,
21 in which symptoms 
induced by b-lactam antibiotics occurred most frequently on 
the skin (63.5%), followed by the cardiovascular system (30.2%), 
bronchus (13.5%), eye/nose (11.5%) and gastrointestinal tract 
Table 5.  Relative risks (odds ratio)
Crude Adjusted
(95% confidence interval) P value (95% confidence interval) P value
For (+) antibiotic test
Skin allergy
Drug allergy
Contact urticaria syndrome (CUS) stage 1
Urticaria
Dermatitis
CUS stage 2
5.87 (1.37-25.20)
4.98 (0.94-26.37)
22.13 (4.49-108.97)
7.66 (1.72-34.20)
100.67 (8.00-1267.3)
0.018
0.095
0.002
0.020
0.002
-
9.68 (1.52-61.50)
13.14 (1.21-142.61)
-
14.00 (0.58-338.78)
0.016
0.034
0.105
For CUS stage 1
Any allergy
Night cough
Skin allergy
(+) antibiotic test
3.17 (1.46-6.88)
2.70 (1.15-6.33)
2.11 (1.03-4.31)
7.66 (1.72-34.20)
0.002
0.041
0.038
0.020
4.35 (1.44-13.11)
-
-
5.56 (1.21-25.64)
0.009
0.028
For contact urticaria
Any allergy
Asthma
(+) antibiotic test
9.35 (1.19-73.69)
8.22 (0.88-76.97)
22.13 (4.49-108.97)
0.012
0.146
0.002
-
10.39 (1.03-105.33)
24.94 (4.96-125.51)
0.048
0.000
For drug allergy
Age
Allergic rhinitis
Asthma
Night cough
Food allergy
Skin allergy
-
5.09 (2.19-11.84)
5.42 (1.04-28.20)
4.87 (2.06-11.52)
12.66 (5.39-29.74)
4.81 (2.20-10.50)
0.000
0.081
0.001
0.000
0.000
1.08 (1.01-1.15)
3.86 (1.23-12.06)
-
3.12 (1.03-9.41)
9.90 (3.38-29.98)
-
0.018
0.020
0.043
0.000
(6.3%). The skin lesions in Gomes et al.
21 included skin rashes 
as well as urticaria and angioedema, and maculopapular or 
morbilliform rashes are the most common drug allergy.
3 How-
ever, as we only asked about the occurrence of urticaria on the 
skin, many subjects probably reported maculopapular or mor-
billiform rashes caused by a T cell-mediated type IV hypersen-
sitivity reaction as urticaria. Those with maculopapular rashes 
showed higher positive responses with the patch test,
25 whereas 
urticaria is usually diagnosed by the skin prick test. If we had 
performed both the skin prick and patch tests, we might have 
obtained higher response rates and different results according 
to skin disease type. However, it was practical challenge to per-
form both tests on all subjects.
The subjects with a positive drug allergy history were older 
with longer durations of employment and contact with antibi-
otics and age was a significant risk factor for drug allergy, sug-
gesting that long-term exposure to antibiotics may result in 
drug allergy. A positive drug allergy history was significantly 
correlated with allergic rhinitis, night cough, food allergy and 
skin allergy as well as sensitization to house dust mites. This in-
dicates that a drug allergy may frequently occur in the skin and 
other organs in subjects with IgE-mediated allergic diseases 
such as allergic rhinitis, especially with sensitization to house 
dust mites. In contrast, when compared according to skin aller-
gy, which included both IgE-mediated urticaria and T cell-me-Allergy Asthma Immunol Res. 2010 April;2(2):114-122.  doi: 10.4168/aair.2010.2.2.114
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diated maculopapular rashes, the difference in the prevalence 
of IgE-mediated allergic diseases such as allergic rhinitis and 
positive skin reactions to house dust mites was not be signifi-
cant, but the difference in the prevalence of CUS, which in-
volves both mechanisms, was significant. A well-known study 
by Adkinson
31 in 1984 reported that the rate of positive respons-
es to the penicillin skin test was not high in atopic subjects. The 
present study found that atopy was significantly related to drug 
allergy. Recently, Apter et al.
32 have also demonstrated that ato-
py, as well as interleukin-4 polymorphism, significantly corre-
lates with drug allergy in patients with a self-reported penicillin 
allergy. A penicillin allergy can be induced by various types of 
allergic reactions in addition to an IgE-mediated reaction and 
therefore the statistical significance of the relationship between 
atopy and drug allergy in a given study may depend on the pro-
portion of study subjects with an IgE-mediated allergic reac-
tion. Once T cell-mediated eczema, a symptom of stage 1 CUS, 
has developed, IgE-mediated stages 2-4 CUS frequently occur 
after the subsequent absorption of allergens through damaged 
skin; furthermore, patients with skin contact allergy to multiple 
agents are easily sensitized to another agent and may more fre-
quently present respiratory tract symptoms of an allergy.
33 Dif-
ferent types of allergic mechanisms appear to augment each 
other.
This study had some limitations. First, we tested only six of the 
currently used antibiotics. Second, because only the skin prick 
test was performed, our results may underestimate the actual 
sensitization rates to antibiotics. To obtain more accurate re-
sults, it would be necessary to perform a patch test to detect T 
cell-mediated allergies and an intradermal test to improve the 
detection sensitivity for IgE-mediated allergies,
27 as well as to 
observe late reactions 1 day after the intradermal test.
19 Gener-
ally, for an intradermal test, cephalosporin is used at a 1:10 di-
lution, which does not induce an irritative reaction,
34 whereas 
cephalosporin is often used without dilution for the skin prick 
test.
19 In the present study, a 1:3 dilution was selected for most 
of the antibiotics used in the skin prick tests. Although this dilu-
tion helped to minimize the false-positive rate due to irritation, 
it created a third limitation, as the false-negative rate due to in-
sufficient antibiotic concentrations might have been higher at 
this dilution. Fourth, because the excluded subjects had a high-
er probability for drug allergies, the skin test response rates in 
the nurse population may be underestimations. Additionally, 
the group of nurses who did not undergo skin tests had less fre-
quent contact with injectable antibiotics; consequently, the 
overall sensitization rate based on the group of nurses who did 
undergo skin tests may be an overestimation. Lastly, female sub-
jects have been shown to have a higher frequency of adverse 
drug reactions and a higher response rate to the penicillin skin 
test, compared with male subjects;
35 thus, because almost all of 
our subjects were female, gender should be considered when 
interpreting our study results.
The results of this study suggest that because adverse reac-
tions to antibiotics occur mainly as skin allergies through type I 
and IV hypersensitivity reactions, positive responses to antibi-
otic skin tests, CUS and drug allergies were more frequently ob-
served in subjects with skin allergies than in those without. 
Based on our results that allergic rhinitis and food allergy were 
important risk factors for drug allergies, as was also shown in a 
recent study,
32 even though drug allergy has been known not to 
be prevalent in atopic subjects, atopy may play a crucial role in 
the development of drug allergy.
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